Novartis Quietly Confident About Prevacid Switch
This article was originally published in The Tan Sheet
You may also be interested in...
Trials in Crohn’s disease and ulcerative colitis are going with plans for filing in both indications. Meanwhile, Takeda’s blockbuster GI drug Prevacid goes generic in May.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning